T46.8X2 Category · further specificity required Poisoning by antivaricose drugs, including sclerosing agents, intentional self-harm
ICD-10-CM T46.8X2 identifies “Poisoning by antivaricose drugs, including sclerosing agents, intentional self-harm” as a category requiring further specificity in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.
Chapter 19: Injury, poisoning and certain other consequences of external causes
Code-level instructions
No additional notes.
Inherited instructions
Chapters 19 · Injury, poisoning and certain other consequences of external causes (S00-T88)
Excludes 22
- birth trauma (P10-P15)
- obstetric trauma (O70-O71)
Use additional code1
code to identify any retained foreign body, if applicable (Z18.-)
Note2
- Use secondary code(s) from Chapter 20, External causes of morbidity, to indicate cause of injury. Codes within the T section that include the external cause do not require an additional external cause code
- The chapter uses the S-section for coding different types of injuries related to single body regions and the T-section to cover injuries to unspecified body regions as well as poisoning and certain other consequences of external causes.
T36-T50 · Poisoning by, adverse effects of and underdosing of drugs, medicaments and biological substances (T36-T50)
Includes4
- adverse effect of correct substance properly administered
- poisoning by overdose of substance
- poisoning by wrong substance given or taken in error
- underdosing by (inadvertently) (deliberately) taking less substance than prescribed or instructed
Excludes 11
toxic reaction to local anesthesia in pregnancy (O29.3-)
Excludes 25
Code first7
Use additional code4
Note1
The drug giving rise to the adverse effect should be identified by use of codes from categories T36-T50 with fifth or sixth character 5.
T46 · Poisoning by, adverse effect of and underdosing of agents primarily affecting the cardiovascular system
Excludes 11
poisoning by, adverse effect of and underdosing of metaraminol (T44.4)
Seventh character1
The appropriate 7th character is to be added to each code from category T46
A — initial encounter
D — subsequent encounter
S — sequela
More specific codes
T46.8X2APoisoning by antivaricose drugs, including sclerosing agents, intentional self-harm, initial encounterBillable / specificT46.8X2DPoisoning by antivaricose drugs, including sclerosing agents, intentional self-harm, subsequent encounterBillable / specificT46.8X2SPoisoning by antivaricose drugs, including sclerosing agents, intentional self-harm, sequelaBillable / specificOfficial index references
Official index references (15)
Antivaricose drug (1)
- Antivaricose drugDrugs and chemicals
Dextrose (1)
- Dextrose › concentrated solution, intravenousDrugs and chemicals
Ethanolamine oleate (1)
- Ethanolamine oleateDrugs and chemicals
Monoethanolamine (2)
- MonoethanolamineDrugs and chemicals
- Monoethanolamine › oleateDrugs and chemicals
Phenol (1)
- Phenol › in oil injectionDrugs and chemicals
Polidocanol (1)
- PolidocanolDrugs and chemicals
Sclerosing agent (1)
- Sclerosing agentDrugs and chemicals
Sodium (3)
- Sodium › morrhuateDrugs and chemicals
- Sodium › psylliateDrugs and chemicals
- Sodium › tetradecyl sulfateDrugs and chemicals
Sotradecol (1)
- SotradecolDrugs and chemicals
Varicose reduction drug (1)
- Varicose reduction drugDrugs and chemicals
Venous sclerosing drug NEC (1)
- Venous sclerosing drug NECDrugs and chemicals
Zinc(compounds) (fumes) (vapor) NEC (1)
- Zinc(compounds) (fumes) (vapor) NEC › antivaricoseDrugs and chemicals
History
Code history
Latest recorded change · FY2025 · 04-01
Effective from
- Inherited rules changed
Poisoning by antivaricose drugs, including sclerosing agents, intentional self-harm
Category — select a more specific code
CDC/NCHS · FY2025 · 04-01All editions (19)
| All editions | Effective from | Code history |
|---|---|---|
| FY2016 | 2015-10-01 | First observed |
| FY2017 | 2016-10-01 | No tabular change |
| FY2018 | 2017-10-01 | No tabular change |
| FY2019 | 2018-10-01 | Inherited rules changed |
| FY2020 | 2019-10-01 | No tabular change |
| FY2020 · April | 2020-04-01 | No tabular change |
| FY2021 | 2020-10-01 | Inherited rules changed |
| FY2021 · 01-01 | 2021-01-01 | No tabular change |
| FY2022 | 2021-10-01 | No tabular change |
| FY2022 · 04-01 | 2022-04-01 | No tabular change |
| FY2023 | 2022-10-01 | No tabular change |
| FY2023 · 04-01 | 2023-04-01 | No tabular change |
| FY2024 | 2023-10-01 | No tabular change |
| FY2024 · 04-01 | 2024-04-01 | No tabular change |
| FY2025 | 2024-10-01 | No tabular change |
| FY2025 · 04-01 | 2025-04-01 | Inherited rules changed |
| FY2026 | 2025-10-01 | No tabular change |
| FY2026 · April | 2026-04-01 | No tabular change |
| FY2027 | 2026-10-01 | No tabular change |
Explore the more specific codes in this category. Reference checks do not establish clinical appropriateness or guarantee reimbursement.